Basics
Description
- Chronic, multisystem disorder characterized by local accumulation of T lymphocytes and mononuclearphagocytes forming noncaseating epithelioid granulomas
- Symptoms mainly due to organ dysfunction due to disruption of local tissue architecture:
- Predominance of lung symptoms
- ACE and Vitamin D levels may be increased due to secretion from granulomatous tissue
- Prevalence 10 " “20/100,000 in US and Europe
- Affects almost all races and geographic locations
- Symptoms typically begin in patients 10 " “40 yr of age
- 2.4% lifetime risk to blacks in US, relative to whites at 0.85%
Etiology
Unclear, but appears to be an overly robust cell-mediated immune response to unidentified self- or nonself antigen(s) ‚
Diagnosis
Signs and Symptoms
History
- Constitutional:
- Fatigue, general weakness
- Fever
- Skin (25% patients):
- Cardiac/respiratory (most patients):
- Dyspnea
- Chest pain
- Palpitations
- Cough
- Hemoptysis
- Neurologic:
- Nerve palsy (usually CN VII)
- Seizure
- Altered mental status
- Ocular (20% patients):
- Renal:
- Musculoskeletal:
Physical Exam
- Constitutional:
- Skin:
- Erythema nodosum
- Subcutaneous nodules
- Maculopapules
- Plaques
- Infiltrative scars
- Lupus pernio
- EENT:
- Uveitis
- Keratoconjunctivitis
- Parotid gland enlargement
- Neurologic:
- Nerve palsy (usually CN VII)
- Respiratory:
- Cardiac ( ¢ ˆ ¼5% patients):
- Dysrhythmias, conduction abnormalities, AV block
- CHF (due to restrictive cardiomyopathy)
- Murmurs (due to papillary muscle dysfunction)
- Renal:
- Musculoskeletal:
- L ƒ ¶fgren syndrome:
- Bilateral hilar adenopathy
- Erythema nodosum
- ‚ ±Polyarthralgias
- Heerfordt " “Waldenstr ƒ ¶m syndrome:
- Fever
- Uveitis
- Parotid gland enlargement
- ‚ ±CN VII palsy
- Children <4 yr old classically present with triad of rash, uveitis, and arthritis.
- Children ≥4 yr old present similarly to adults.
Essential Workup
- Physical exam with emphasis on lung, skin, eye, heart, and musculoskeletal
- Pulse oximetry/ABG
- ECG (dysrhythmias, conduction delays)
- Slit-lamp eye exam
Diagnosis Tests & Interpretation
Lab
- Serum ACE elevated in 75% cases
- Basic chemistry panel
- LFTs: Mild, usually asymptomatic, mainly elevated alk phos but possible mild elevation transaminases
- Serum calcium: Hypercalcemia due to excessive vitamin D
- UA: Hypercalciuria
- Hypergammaglobulinemia
- CSF analysis: Lymphocyte predominance, elevated ACE level
Imaging
Chest radiograph (abnormal in 90% sarcoid patients) " ”reason for frequent incidental diagnosis: ‚
- Type 1: Bilateral hilar lymphadenopathy
- Type 2: Lymphadenopathy and parenchymal lung changes (reticular opacities)
- Type 3: Parenchymal lung changes without hilar lymphadenopathy
- Type 4: Reticular opacities, pulmonary fibrosis; particularly in upper lobes
- Radiotracer scans may identify granulomatous disease but is nonspecific
Diagnostic Procedures/Surgery
- Biopsy:
- Bronchoscopy and bronchoalveolar lavage
- Skin lesions if feasible
- Kveim " “Siltzbach test:
- Subcutaneous injection of antigen with subsequent spleen biopsy
- Rarely used
Differential Diagnosis
- HIV
- Interstitial lung disease
- Lymphoma
- Mycobacterial infection
- Parathyroid disease
Treatment
Pre-Hospital
Provide supplemental oxygen. ‚
Initial Stabilization/Therapy
- Provide supplemental oxygen.
- Monitor for dysrhythmias.
Ed Treatment/Procedures
- Patients should be observed without therapy, if possible, since disease resolves spontaneously in 50% patients.
- Initiate steroids in patients demonstrating 1 of the following:
- Symptomatic or progressive stage II pulmonary disease
- Stage III pulmonary disease
- Malignant hypercalcemia
- Severe ocular disease
- Neurologic sequelae
- Nasopharyngeal/laryngeal involvement
- Consider topical corticosteroids and cycloplegic agents for anterior uveitis or dermatologic manifestations.
Medication
- Prednisone: 10 " “80 mg (peds: 0.5 " “2 mg/kg) PO QD
- Lower doses for hypercalcemic nephropathy and mild to moderate disease
- Higher doses for neurosarcoidosis
Follow-Up
Disposition
Admission Criteria
- Hypoxia
- Patients with moderate to severe respiratory symptoms
- Significant cardiac conduction delays
- Severe thrombocytopenia
Discharge Criteria
Follow-up is established. ‚
Issues for Referral
- Cardiology:
- For any conduction disturbances or CHF
- Rheumatology:
- For routine care and follow-up:
- ¢ ˆ ¼q2mo for patients with active disease on steroids, q3 " “4mo for asymptomatic patients
- Pulmonary:
- For formal pulmonary function testing (to monitor for progression of restrictive lung disease) with spirometry and DLCO
- Ophthalmology:
- Within 48 hr for acute uveitis
Follow-Up Recommendations
- Restrict excess calcium from the diet.
- Monitor for complications related to chronic steroid therapy
Pearls and Pitfalls
- Evaluate patients with chest radiographs to determine stage and progression of disease.
- Prednisone is treatment of choice for exacerbations of disease.
- Monitor for signs of hypercalcemia and related complications.
- Be aware of acute neurologic and ocular sequelae.
Additional Reading
- Baughman ‚ RP. Pulmonary sarcoidosis. Clin Chest Med. 2004;25:521 " “530.
- Fauci ‚ AS, Braunwald ‚ E, Kasper ‚ DL, et al. Harrisons principles of internal medicine. 17th ed. New York, NY: McGraw-Hill Professional; 2008.
- Iannuzzi ‚ MC, Rybicki ‚ BA, Teirstein ‚ AS. Sarcoidosis. N Engl J Med. 2007;357:2153 " “2165.
- King ‚ TE. Sarcoidosis. Updated Apr 18, 2011. Available at www.UpToDate.com. Accessed on January 2013.
See Also (Topic, Algorithm, Electronic Media Element)
- Dyspnea
- HIV/AIDS
- Hyperparathyroidism
- Tuberculosis
Codes
ICD9
- 135 Sarcoidosis
- 517.8 Lung involvement in other diseases classified elsewhere
ICD10
- D86.0 Sarcoidosis of lung
- D86.3 Sarcoidosis of skin
- D86.9 Sarcoidosis, unspecified
- D86.85 Sarcoid myocarditis
- D86.1 Sarcoidosis of lymph nodes
- D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
- D86.81 Sarcoid meningitis
- D86.82 Multiple cranial nerve palsies in sarcoidosis
- D86.83 Sarcoid iridocyclitis
- D86.84 Sarcoid pyelonephritis
- D86.86 Sarcoid arthropathy
- D86.87 Sarcoid myositis
- D86.89 Sarcoidosis of other sites
- D86.8 Sarcoidosis of other sites
- D86 Sarcoidosis
SNOMED
- 31541009 Sarcoidosis (disorder)
- 24369008 Pulmonary sarcoidosis (disorder)
- 55941000 cutaneous sarcoidosis (disorder)
- 75403004 Cardiac sarcoidosis
- 193251003 Sarcoid myopathy
- 230193008 Neurosarcoidosis
- 234526006 Ocular sarcoidosis (disorder)
- 64757003 lymph node sarcoidosis (disorder)